Efficacy of a nutraceutical combination on lipid metabolism in patients with metabolic syndrome: a multicenter, double blind, randomized, placebo controlled trial

Efficacy of a nutraceutical combination on lipid metabolism in patients with metabolic syndrome: a multicenter, double blind, randomized, placebo controlled trial

Abstract Background Nutraceuticals represent a new therapeutic frontier in the treatment of metabolic syndrom (MetS) and related cardiovascular risk factors. The aim of this study was to evaluate the potential beneficial effects of Armolipid Plus (AP) (berberine 500 mg, red yest rice, monacolin K 3 ...

ver descrição completa

Detalhes bibliográficos
Main Authors: Ferruccio Galletti, Valeria Fazio, Marco Gentile, Giuseppe Schillaci, Giacomo Pucci, Francesca Battista, Valentina Mercurio, Giorgio Bosso, Domenico Bonaduce, Nadia Brambilla, Cristina Vitalini, Massimo D’Amato, Giampaolo Giacovelli
Formato: Artigo
Idioma:English
Publicado em: BMC 2019-03-01
Colecção:Lipids in Health and Disease
Acesso em linha:http://link.springer.com/article/10.1186/s12944-019-1002-y

Internet

http://link.springer.com/article/10.1186/s12944-019-1002-y

Registos relacionados